Abstract
This Frost & Sullivan research service titled European Diabetes Market provides an overview of current treatment options, drugs in pipeline, technological advancements in diabetes and revenues of the current delivery methods. The study also offers a complete analysis of key market drivers, restraints, and trends prevailing in the European market. In this research, Frost & Sullivan's expert analysts thoroughly examine the markets for insulin and OAD drugs.
View Cart
